Clinical Trials
4 trialsNCT03761069 2022-02-02
Study of PTC299 (Emvododstat) in Relapsed/Refractory Acute Leukemias
PTC Therapeutics
Phase 1 Terminated
NCT00704821 2019-05-10
PTC299 for Treatment of Advanced Cancer
PTC Therapeutics
Phase 1 Terminated
NCT00911248 2019-04-12
PTC299 for Treatment of Neurofibromatosis Type 2
PTC Therapeutics
Phase 2 Terminated
NCT00508586 2016-03-03
PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer
PTC Therapeutics
Phase 1 Completed